Table of Contents

Part A: Synthesis and characterization of polymeric micelles for drug delivery
1. Polymeric micelles: pre´ cis for past, present, and future
2. Various polymers in the development of polymeric micelles
3. Solubility enhancement and drug release mechanism of polymeric micelles
4. Polymeric micellar nanomedicine for enhanced permeability and retention effect
5. Polymeric micelles for oral drug delivery
6. Polymeric micellar nanocarriers: topical treatment of inflammatory diseases

Part B: Application of polymeric micelles in drug delivery
7. Polymeric micelles in dermal and transdermal drug delivery
8. Polymeric micelles as delivery systems for anticancer immunotherapy
9. Polymeric micelles for drug delivery in oncology
10. Surface engineering of polymeric micelles for imparting multifunctionality
11. Cellular interaction of polymeric micelles in targeted drug delivery systems: the road from tissue to cell

Part C: Stimuli-responsive polymeric micelles for drug delivery
12. pH-responsive polymeric micelles for drug delivery
13. Enzyme-responsive polymeric micelles for drug delivery applications
14. Light- and temperature-responsive polymeric micelles for drug delivery
15. Exogenous stimuli
16. Dual-responsive polymeric micelles for drug delivery

Part D: Recent advances in polymeric micelles
17. Polymeric micelles for drug codelivery
18. Nose-to-brain delivery
19. The application of a drug
20. Polymeric micelles with cleavable links for drug delivery
21. Block copolymer micelles as long-circulating drug delivery vehicles
22. Triblock polymeric micelles as an emerging nanocarrier for drug delivery

Part E: Environmental and regulatory aspects
23. Biological toxicity and environmental hazards associated with polymeric micelles
24. Clinical translation of polymeric micelles into market
25. Regulatory pathways and prospects for polymeric micelles

About the Author

Dr. Prashant Kesharwani is assistant professor of Pharmaceutics at Department of Pharmaceutical Sciences, Dr. Harisingh Gour Vishwavidyalaya, Sagar, Madhya Pradesh, India. He has more than 12 years of teaching, research, and industrial experience at international levels from various countries, including the United States, Malaysia, and India. An overarching goal of his current research is the development of nanoengineered drug delivery systems for various diseases. He has more than 350 international publications in well-reputed journals and more than 25 international books (Elsevier). He is a recipient of many research grants from various funding bodies. He is also the recipient of several internationally acclaimed awards, such as “USERN Laureate award”, most prestigious “SERB-Ramanujan Fellowship Award”. He actively participates in outreach and scientific dissemination for the service of the wider community. His Number of citations is = 26779; h-index = 85; i-10 index = 370 (According to google scholar on March 2025). He has more than 30 international publications published in very high impact factor journals (Progress in Polymer Sciences IF 32.063, Molecular Sciences IF 41.444, Progress in Material Sciences IF 48.580, Advanced Materials IF 29.4, Drug Resistance Update IF 22.841 and Material Todays IF 32.072). He has presented many invited talks and oral presentations at prestigious scientific peer-conferences, received international acclaims and awards for research contribution, supervised students/junior researchers and actively participated in outreach and scientific dissemination for the service of the wider community.

Dr. Khaled Greish is Professor of Molecular Medicine, and head of the Nano-research unit, at Princes Al-Jawhara Center, Arabian Gulf University, Kingdom of Bahrain. His previous appointments included Senior lecturer of Pharmacology at the University of Otago, New Zealand, and Assistant Professor of Pharmaceutical Chemistry at University of Utah (UT, USA). He has published > 70 peer reviewed papers, and 10 book chapters in the field of targeted anticancer drug delivery. Controlled Release Society (CRS) awarded him the CRS Postdoctoral Achievement Award in 2008 and in 2010; he was elected as member of the CRS College of Fellows. In recognition of his research, University of Otago awarded him “Early Career Awards for Distinction in Research” in 2014. His research focuses on Nanomedicine, tumor vascular biology, and anticancer drug discovery/development.